查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1886288

临床试验影像市场－全球产业规模、份额、趋势、机会和预测，依产品和服务、影像方式、最终用户、地区和竞争格局划分，2020-2030年预测

Clinical Trial Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product and Service, By Modality, By End-User, By Region, By Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年全球临床试验影像市场规模为11.8亿美元，预计2030年将以7.30%的复合年增长率成长至18亿美元。临床试验影像市场涵盖了磁振造影、电脑断层扫描和正子断层扫描等医学影像技术的应用，旨在客观评估临床开发过程中试验性疗法的安全性和有效性。

市场概览
预测期 2026-2030
市场规模：2024年 11.8亿美元
市场规模：2030年 18亿美元
复合年增长率：2025-2030年 7.30%
成长最快的细分市场 电脑断层扫描
最大的市场 北美洲

主要市场驱动因素

随着製药和生物技术公司不断拓展治疗产品线，全球临床试验数量的持续成长是推动临床试验影像市场发展的关键因素。这种扩张需要对药物安全性和有效性进行全面的影像评估，从而直接增加了对专业服务的需求。

主要市场挑战

影像设备所需的大量资本支出直接阻碍了全球临床试验影像市场的成长。购置和维护先进医学影像设备（例如磁振造影或正子断层扫描系统）的高昂成本，给临床试验中心和合约研究组织带来了沉重的经济负担。

主要市场趋势

分散式和混合式临床试验模式的采用，从根本上重塑了全球临床试验影像市场的营运策略，提高了病患就诊便利性，简化了资料收集流程。这种方法整合了远距医疗和穿戴式装置等远距技术，减少了患者现场就诊的需求，从而扩大了受试者招募的地域范围。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球临床试验影像市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品及服务分类（试验设计咨询服务、读取分析服务、手术影像服务、影像软体）
    • 依检查方式分类（磁振造影、电脑断层扫描、超音波、正子断层扫描、X光、超音波心动图、其他检查方式）
    • 按最终用户（製药和生物技术公司、医疗器材製造商、学术和政府研究机构）划分
    • 按地区
    • 按公司（2024 年）
  • 市场地图

第六章：北美临床试验影像市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲临床试验影像市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区临床试验影像市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲临床试验影像市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章：南美洲临床试验影像市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章：市场动态

  • 司机
  • 挑战

第十二章：市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章：全球临床试验影像市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章：竞争格局

  • Clario Medical Imaging Inc
  • Icon PLC
  • Ixico PLC
  • Koninklijke Philips NV
  • Medpace
  • Navitas Clinical Research, Inc
  • Parexel International Corporation
  • ProScan Imaging
  • Radiant Sage LLC
  • Resonance Health

第十六章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 22206

The Global Clinical Trial Imaging Market, valued at USD 1.18 Billion in 2024, is projected to experience a CAGR of 7.30% to reach USD 1.80 Billion by 2030. The clinical trial imaging market encompasses the application of medical imaging modalities, such as Magnetic Resonance Imaging, Computed Tomography, and Positron Emission Tomography, to objectively assess the safety and efficacy of investigational therapeutics throughout clinical development.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.18 Billion
Market Size 2030USD 1.80 Billion
CAGR 2025-20307.30%
Fastest Growing SegmentComputed Tomography
Largest MarketNorth America

Key Market Drivers

The increasing global clinical trial volume is a fundamental driver for the clinical trial imaging market as pharmaceutical and biotechnology companies expand therapeutic pipelines. This expansion necessitates comprehensive imaging for drug safety and efficacy assessments, directly increasing demand for specialized services. This growth is evidenced by the rising number of registered studies; according to ClinicalTrials. gov, as of October 10, 2025, the number of registered studies reached 74,339.

Key Market Challenges

The substantial capital expenditure required for imaging equipment directly impedes the growth of the Global Clinical Trial Imaging Market. The high cost of acquiring and maintaining advanced medical imaging modalities, such as Magnetic Resonance Imaging or Positron Emission Tomography systems, places a significant financial burden on clinical trial sites and contract research organizations. This barrier limits the ability of many entities, particularly smaller or emerging research centers, to invest in the latest technology or expand their imaging capabilities.

Key Market Trends

The adoption of decentralized and hybrid clinical trial models is fundamentally reshaping operational strategies within the global clinical trial imaging market by enhancing patient accessibility and streamlining data collection. This approach integrates remote technologies such as telemedicine and wearable devices, reducing the need for extensive on-site patient visits and thereby broadening the geographic reach for participant recruitment. TransCelerate BioPharma's 2024 Annual Report indicates that both mature and newer initiatives have achieved 75% or higher adoption rates among their member companies in recent years, reflecting the increasing integration of flexible trial designs.

Key Market Players

  • Clario Medical Imaging Inc
  • Icon PLC
  • Ixico PLC
  • Koninklijke Philips N.V
  • Medpace
  • Navitas Clinical Research, Inc
  • Parexel International Corporation
  • ProScan Imaging
  • Radiant Sage LLC
  • Resonance Health

Report Scope:

In this report, the Global Clinical Trial Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Trial Imaging Market, By Product and Service:

  • Trial Design Consulting Services
  • Read Analysis Services
  • Operational Imaging Services
  • Imaging Software

Clinical Trial Imaging Market, By Modality:

  • Magnetic Resonance Imaging
  • Computed Tomography
  • Ultrasound
  • Positron Emission Tomography
  • X-Ray
  • Echocardiography
  • Other Modalities

Clinical Trial Imaging Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers
  • Academic and Government Research Institute

Clinical Trial Imaging Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Clinical Trial Imaging Market.

Available Customizations:

Global Clinical Trial Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clinical Trial Imaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product and Service (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, Imaging Software)
    • 5.2.2. By Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, Other Modalities)
    • 5.2.3. By End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic and Government Research Institute)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Clinical Trial Imaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product and Service
    • 6.2.2. By Modality
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Clinical Trial Imaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product and Service
        • 6.3.1.2.2. By Modality
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Clinical Trial Imaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product and Service
        • 6.3.2.2.2. By Modality
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Clinical Trial Imaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product and Service
        • 6.3.3.2.2. By Modality
        • 6.3.3.2.3. By End User

7. Europe Clinical Trial Imaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service
    • 7.2.2. By Modality
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Clinical Trial Imaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product and Service
        • 7.3.1.2.2. By Modality
        • 7.3.1.2.3. By End User
    • 7.3.2. France Clinical Trial Imaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product and Service
        • 7.3.2.2.2. By Modality
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Clinical Trial Imaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product and Service
        • 7.3.3.2.2. By Modality
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Clinical Trial Imaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product and Service
        • 7.3.4.2.2. By Modality
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Clinical Trial Imaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product and Service
        • 7.3.5.2.2. By Modality
        • 7.3.5.2.3. By End User

8. Asia Pacific Clinical Trial Imaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service
    • 8.2.2. By Modality
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Clinical Trial Imaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product and Service
        • 8.3.1.2.2. By Modality
        • 8.3.1.2.3. By End User
    • 8.3.2. India Clinical Trial Imaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product and Service
        • 8.3.2.2.2. By Modality
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Clinical Trial Imaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product and Service
        • 8.3.3.2.2. By Modality
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Clinical Trial Imaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product and Service
        • 8.3.4.2.2. By Modality
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Clinical Trial Imaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product and Service
        • 8.3.5.2.2. By Modality
        • 8.3.5.2.3. By End User

9. Middle East & Africa Clinical Trial Imaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service
    • 9.2.2. By Modality
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Clinical Trial Imaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product and Service
        • 9.3.1.2.2. By Modality
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Clinical Trial Imaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product and Service
        • 9.3.2.2.2. By Modality
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Clinical Trial Imaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product and Service
        • 9.3.3.2.2. By Modality
        • 9.3.3.2.3. By End User

10. South America Clinical Trial Imaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product and Service
    • 10.2.2. By Modality
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Clinical Trial Imaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product and Service
        • 10.3.1.2.2. By Modality
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Clinical Trial Imaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product and Service
        • 10.3.2.2.2. By Modality
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Clinical Trial Imaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product and Service
        • 10.3.3.2.2. By Modality
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Clinical Trial Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Clario Medical Imaging Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Icon PLC
  • 15.3. Ixico PLC
  • 15.4. Koninklijke Philips N.V
  • 15.5. Medpace
  • 15.6. Navitas Clinical Research, Inc
  • 15.7. Parexel International Corporation
  • 15.8. ProScan Imaging
  • 15.9. Radiant Sage LLC
  • 15.10. Resonance Health

16. Strategic Recommendations

17. About Us & Disclaimer